𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Experience with long-term treatment with albumin-supplemented botulinum toxin type A

✍ Scribed by Bahram Mohammadi; Katja Kollewe; Maresa Wegener; Hans Bigalke; Reinhard Dengler


Book ID
106207522
Publisher
Springer
Year
2009
Tongue
English
Weight
158 KB
Volume
116
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Frey syndrome : Treatment with type A bo
✍ Jens J. von Lindern; Bernd Niederhagen; Stefan BergΓ©; Georg HΓ€gler; Rudolf H. Re πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 448 KB πŸ‘ 1 views

## Background: Frey syndrome was first described by baillarger in 1853. frey provided a detailed analysis and description as "auriculotemporal syndrome" in 1923. according to the literature, even the most recent therapeutic measures described for the treatment of patients with frey syndrome have li

Long-term botulinum toxin treatment incr
✍ Inger Marie Skogseid; Jo RΓΈislien; BjΓΈrgulf Claussen; Emilia Kerty πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 153 KB

## Abstract We examined the impact of cervical dystonia (CD) and long‐term botulinum toxin (BTX) treatment on employment status. Data on employment status at onset of CD, at initiation of BTX treatment, and at evaluation of long‐term treatment were obtained from 62 CD patients aged 31–66 years (med

Long-term treatment with botulinum toxin
✍ Mitchell F. Brin; Cynthia L. Comella; Joseph Jankovic; Francis Lai; Markus Nauma πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 103 KB

## Abstract To evaluate the immunogenicity of botulinum toxin type A (BoNTA; BOTOX) in cervical dystonia (CD). Subjects diagnosed with CD for β‰₯1 year and previously naΓ―ve to BoNTs were treated with BoNTA in a prospective, open‐label, multicenter study. Serum samples were analyzed for BoNTA neutrali